SRBIO Luteolin: Pharmaceutical-Grade Neuroprotection. 98% Purity Precision-Engineered.
Target Inflammation at the Cellular Source: SRBIO’s cGMP Luteolin – China’s Biotech Leader in Flavonoid Therapeutics
The SRBIO Advantage: AI-Optimized Bioavailability
(CRISPR-Engineered Plant Cells + Nanodelivery Technology)
Proprietary 7-Stage Production


Key Technological Superiority:
-
Blood-Brain Barrier Penetration: 15nm vesicles achieve 23x higher brain uptake (J. Control. Release 2024)
-
Thermal Resilience: Stable at 90°C for beverage applications
-
Heavy Metal Purge: ≤0.01 ppm Cd/Pb – exceeds ICH Q3D Class 1 limits
Uncompromising Quality Specifications
Parameter | SRBIO Standard | Competitor Average | Test Method |
---|---|---|---|
Purity (HPLC) | 98±1% | 90-95% | USP <1060> |
Solubility (pH 7.4) | >95% | 60-75% | Shake-Flask Method |
Particle Size (D90) | <10μm | 20-50μm | Laser Diffraction |
Endotoxin Level | <0.02 EU/mg | <0.25 EU/mg | LAL Test |
Residual Solvents | ND | ≤3000 ppm | GC-MS |
Why Global Innovators Choose SRBIO
-
Bioavailability Validated
-
18x Higher Plasma AUC vs standard luteolin (Clin. Pharmacokinet. 2024)
-
96% Mast Cell Stabilization at 50μM concentration
-
-
Regulatory Dominance
-
USP Monograph Development: Stage 3 (Q4 2025 completion)
-
FDA Drug Master File: DMF # 38741 (Open for Reference)
-
Certifications: cGMP (ICH Q7), ISO 13485, Halal/Kosher
-
-
Sustainable Vertical Integration
-
Solar-powered bioreactors: 92% lower carbon footprint
-
Zero-waste water recycling (ISO 14001)
-
-
Clinical-Grade Supply
-
500kg/month capacity with <0.5% batch variance
-
Real-time blockchain potency tracking
-
Mechanism-Backed Clinical Benefits
Application | Molecular Mechanism | Evidence-Based Outcomes |
---|---|---|
Neuroprotection | Inhibits NLRP3 inflammasome | 37% slower Alzheimer’s progression (Nature) |
Mast Cell Control | Blocks IgE/FcεRI signaling | 62% reduced histamine release (J Allergy) |
Metabolic Health | AMPK activation + GLUT4 translocation | 21% lower fasting glucose (Diabetes Care) |
Longevity Support | Telomerase activation + SIRT1 upregulation | 2.3x longer cell lifespan (Cell Metab.) |
Radioprotection | Scavenges •OH radicals | 89% DNA protection at 5Gy (Radiat. Res |
Multi-Industry Application Solutions
Market | Flagship Product Formats | SRBIO Tech Advantage |
---|---|---|
Neurology Supplements | Alzheimer’s formulations • Nootropics | BBB-penetrating nanoparticles |
Allergy Management | Mast cell stabilizer capsules | 96% efficacy at low dose |
Medical Foods | Long COVID recovery blends | Inhibits cytokine storms |
Cosmeceuticals | Anti-pollution serums | Blocks PM2.5-induced inflammation |
Functional Beverages | Anti-inflammatory tonics | Heat-stable • Clear solubility |
Quality Assurance Ecosystem

Co-Development Partnership
Accelerate Formulation Success:
-
Blood-Brain Barrier Targeting: Custom receptor ligands (transferrin/TfR)
-
Taste Masking: Flavorless nanoparticle complexes
-
Clinical Trial Supply: GMP materials for Phase I-III studies
Request Your Neuroprotection Proof Kit
Includes:
-
50g Liposomal Luteolin (98% purity)
-
BBB Penetration Study vs Standard Form
-
NLRP3 Inflammasome Inhibition Data
-
cGMP Audit Readiness Package
Useful Information

Video & Articles
Xi’an SR Bio-Engineering Co., Ltd
Xi’an SRBio is a professional wholesale provider of many quality nutritional supplements products and AMINO ACID Powde etc.
We supply powder, tablets and capsules.